PL2726091T3 - Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek - Google Patents
Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lekInfo
- Publication number
- PL2726091T3 PL2726091T3 PL12803759T PL12803759T PL2726091T3 PL 2726091 T3 PL2726091 T3 PL 2726091T3 PL 12803759 T PL12803759 T PL 12803759T PL 12803759 T PL12803759 T PL 12803759T PL 2726091 T3 PL2726091 T3 PL 2726091T3
- Authority
- PL
- Poland
- Prior art keywords
- lumen
- therapeutic agent
- intestinal tract
- agent preparations
- swallowable drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161571687P | 2011-06-29 | 2011-06-29 | |
| US201161571679P | 2011-06-29 | 2011-06-29 | |
| US201161571632P | 2011-06-29 | 2011-06-29 | |
| US201161571633P | 2011-06-29 | 2011-06-29 | |
| US201161571686P | 2011-06-29 | 2011-06-29 | |
| US201161571643P | 2011-06-29 | 2011-06-29 | |
| US201161571634P | 2011-06-29 | 2011-06-29 | |
| US201161571641P | 2011-06-29 | 2011-06-29 | |
| US201161571649P | 2011-06-30 | 2011-06-30 | |
| US201161571619P | 2011-06-30 | 2011-06-30 | |
| US201161571652P | 2011-06-30 | 2011-06-30 | |
| US201161571631P | 2011-06-30 | 2011-06-30 | |
| US201161571642P | 2011-06-30 | 2011-06-30 | |
| US201161571648P | 2011-06-30 | 2011-06-30 | |
| US201161571650P | 2011-06-30 | 2011-06-30 | |
| EP12803759.5A EP2726091B1 (en) | 2011-06-29 | 2012-06-29 | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| PCT/US2012/045138 WO2013003824A1 (en) | 2011-06-29 | 2012-06-29 | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2726091T3 true PL2726091T3 (pl) | 2020-08-10 |
Family
ID=47424583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12803759T PL2726091T3 (pl) | 2011-06-29 | 2012-06-29 | Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP3653224A1 (pl) |
| JP (5) | JP6029664B2 (pl) |
| CN (2) | CN109008910B (pl) |
| AU (1) | AU2012275112B2 (pl) |
| CA (2) | CA3070695C (pl) |
| DK (1) | DK2726091T3 (pl) |
| ES (1) | ES2773115T3 (pl) |
| PL (1) | PL2726091T3 (pl) |
| PT (1) | PT2726091T (pl) |
| WO (1) | WO2013003824A1 (pl) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102770151B (zh) | 2009-08-03 | 2018-07-31 | 因卡伯实验室有限责任公司 | 用于刺激肠道内肠促胰岛素产生的吞咽式囊和方法 |
| US8562589B2 (en) | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| AU2011302645B2 (en) | 2010-09-15 | 2015-02-26 | Applied Molecular Transport, Llc | Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences |
| US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
| US8764733B2 (en) | 2010-12-23 | 2014-07-01 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8809271B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9149617B2 (en) | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| EP3653224A1 (en) * | 2011-06-29 | 2020-05-20 | Rani Therapeutics, LLC | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| AU2014240401B2 (en) * | 2013-03-15 | 2018-11-15 | Rani Therapeutics, Llc | Device for oral delivery of therapeutic compounds |
| KR20230154480A (ko) | 2014-05-07 | 2023-11-08 | 어플라이드 몰레큘라 트랜스포트 인크. | 생물학적 활성 화물의 경구 전달용 콜릭스 독소-유래 융합 분자 |
| CN107072955B (zh) | 2014-05-15 | 2021-06-18 | 拉尼医疗有限公司 | 包含多肽和/或蛋白质的固体块的药物组合物和该固体块的制备方法 |
| US11548940B2 (en) | 2014-05-15 | 2023-01-10 | Rani Therapeutics, Llc | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2016042302A1 (en) | 2014-09-17 | 2016-03-24 | Mars, Incorporated | Device |
| CA2961127C (en) * | 2014-09-17 | 2023-07-25 | Mars, Incorporated | Sampling device with ejecting compartment |
| CN113546036A (zh) | 2015-05-01 | 2021-10-26 | 拉尼医疗有限公司 | 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法 |
| EP3294273A4 (en) * | 2015-05-08 | 2018-12-05 | Incube Labs, LLC | Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2017004623A1 (en) | 2015-07-02 | 2017-01-05 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| CN108401419A (zh) * | 2015-09-08 | 2018-08-14 | 因库博实验室有限责任公司 | 使用可吞服药物递送装置递送到肠道内腔中的pcsk9抗体制剂 |
| WO2017156347A1 (en) * | 2016-03-09 | 2017-09-14 | Incube Labs, Llc | Methods and articles for delivering viable cells into solid tissue |
| KR102737336B1 (ko) | 2016-09-09 | 2024-12-05 | 비오라 쎄라퓨틱스, 인크. | 분배가능한 물질의 전달을 위한 전자기계식 섭취가능한 디바이스 |
| EP3600416B1 (en) * | 2017-03-30 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| CN108095806B (zh) * | 2017-12-16 | 2023-04-28 | 重庆金山科技（集团）有限公司 | 带自锁功能的吸附穿刺固定装置 |
| DK3727555T3 (da) * | 2017-12-18 | 2023-06-26 | Biograil ApS | Oral delivery of active drug substances |
| PL3762009T3 (pl) | 2018-03-08 | 2022-09-12 | Applied Molecular Transport Inc. | Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego |
| CN112020343B (zh) * | 2018-03-30 | 2023-09-19 | 维布兰特公司 | 包括振动胶囊的胃肠治疗系统以及其使用方法 |
| US20200038000A1 (en) * | 2018-08-06 | 2020-02-06 | Nimble Science Ltd. | Ingestible apparatus and method for collecting samples in the gastrointestinal tract and/or delivering health-related fluid thereto |
| US12128133B2 (en) * | 2018-09-25 | 2024-10-29 | Rani Therapeutics, Llc | Ingestible device with expandable enclosure |
| BR112021009001A8 (pt) | 2018-11-07 | 2021-10-26 | Applied Molecular Transport Inc | Veículos derivados de cholix para administração oral de carga útil heteróloga |
| EP4083058A3 (en) | 2018-11-07 | 2023-01-11 | Applied Molecular Transport Inc. | Delivery constructs for transcytosis and related methods |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| BR112021012959A2 (pt) * | 2018-12-31 | 2021-09-08 | Rani Therapeutics, Llc | Preparações de agente terapêutico para a liberação em um lúmen do trato intestinal pela utilização de um dispositivo de liberação de fármaco engolível |
| US11771829B2 (en) * | 2019-02-01 | 2023-10-03 | Massachusetts Institute Of Technology | Systems and methods for liquid injection |
| KR20220066056A (ko) | 2019-08-16 | 2022-05-23 | 어플라이드 몰레큘라 트랜스포트 인크. | 조성물, 제형, 및 인터루킨 제조 및 정제 |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| US20230076683A1 (en) * | 2021-09-03 | 2023-03-09 | Alma Therapeutics Ltd | Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall |
| US20250295592A1 (en) * | 2024-03-20 | 2025-09-25 | Jes Tougaard Gram | Method for Controlled Release Oral Drug Delivery |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60129057A (ja) * | 1983-12-14 | 1985-07-10 | 住友化学工業株式会社 | 針状固形製剤投与針 |
| DK42093D0 (da) * | 1993-04-07 | 1993-04-07 | Bukh Meditec | Administrationsmetode |
| GB2379390B (en) * | 2001-09-11 | 2005-01-26 | Caretek Medical Ltd | A novel drug delivery technology |
| CA2490137C (en) * | 2002-06-25 | 2012-01-03 | Sung-Yun Kwon | Rapidly dissolving micro-perforator for drug delivery and other applications |
| US8062573B2 (en) * | 2002-09-16 | 2011-11-22 | Theraject, Inc. | Solid micro-perforators and methods of use |
| AU2003288516A1 (en) * | 2002-12-26 | 2004-07-22 | Given Imaging Ltd. | Immobilizable in vivo sensing device |
| EP1594477A4 (en) * | 2003-01-29 | 2009-07-15 | Pill Pharma Ltd E | ACTIVE MEDICATION CONTRIBUTION IN THE DIGESTIVE TUBE |
| FR2854072B1 (fr) * | 2003-04-23 | 2006-08-04 | Centre Nat Rech Scient | Vecteur pour administration par voie orale |
| WO2006077528A2 (en) * | 2005-01-18 | 2006-07-27 | Koninklijke Philips Electronics, N.V. | Electronically controlled capsule |
| JP4402648B2 (ja) * | 2005-12-16 | 2010-01-20 | オリンパス株式会社 | 被検体内導入装置 |
| GB0603252D0 (en) * | 2006-02-17 | 2006-03-29 | Axcess Ltd | Dissolution aids for oral peptide delivery |
| BRPI0908292B1 (pt) * | 2008-05-05 | 2022-09-20 | Oramed Ltd | Métodos e composições para administração oral de exenatida |
| WO2010093834A2 (en) * | 2009-02-12 | 2010-08-19 | Incube Labs, Llc | Skin penetrating device and method for subcutaneous solid drug delivery |
| HUP0900482A2 (en) * | 2009-08-03 | 2011-03-28 | Cera Med Kft | Pharmaceutical formulation for oral administration |
| US8562589B2 (en) * | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
| CN105999526B (zh) * | 2009-12-24 | 2019-07-05 | 拉尼医疗有限公司 | 可吞咽式药剂递送装置和药剂递送方法 |
| EP3653224A1 (en) * | 2011-06-29 | 2020-05-20 | Rani Therapeutics, LLC | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
-
2012
- 2012-06-29 EP EP19203960.0A patent/EP3653224A1/en not_active Withdrawn
- 2012-06-29 CA CA3070695A patent/CA3070695C/en active Active
- 2012-06-29 DK DK12803759.5T patent/DK2726091T3/da active
- 2012-06-29 CN CN201811010516.9A patent/CN109008910B/zh active Active
- 2012-06-29 EP EP12803759.5A patent/EP2726091B1/en active Active
- 2012-06-29 PL PL12803759T patent/PL2726091T3/pl unknown
- 2012-06-29 CA CA2840617A patent/CA2840617C/en active Active
- 2012-06-29 AU AU2012275112A patent/AU2012275112B2/en active Active
- 2012-06-29 PT PT128037595T patent/PT2726091T/pt unknown
- 2012-06-29 CN CN201280041950.8A patent/CN104023740B/zh active Active
- 2012-06-29 JP JP2014519201A patent/JP6029664B2/ja active Active
- 2012-06-29 ES ES12803759T patent/ES2773115T3/es active Active
- 2012-06-29 WO PCT/US2012/045138 patent/WO2013003824A1/en not_active Ceased
-
2016
- 2016-08-22 JP JP2016161689A patent/JP6663326B2/ja active Active
-
2018
- 2018-12-26 JP JP2018242039A patent/JP6745866B2/ja active Active
-
2020
- 2020-08-04 JP JP2020132281A patent/JP7102470B2/ja active Active
-
2022
- 2022-06-03 JP JP2022091035A patent/JP7305008B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2726091B1 (en) | 2020-01-22 |
| JP2014520812A (ja) | 2014-08-25 |
| CN104023740A (zh) | 2014-09-03 |
| CA3070695C (en) | 2024-01-23 |
| EP2726091A1 (en) | 2014-05-07 |
| DK2726091T3 (da) | 2020-03-09 |
| AU2012275112A1 (en) | 2014-01-23 |
| JP7102470B2 (ja) | 2022-07-19 |
| JP2020192342A (ja) | 2020-12-03 |
| JP6029664B2 (ja) | 2016-11-24 |
| EP3653224A1 (en) | 2020-05-20 |
| CA2840617C (en) | 2020-03-24 |
| CA3070695A1 (en) | 2013-01-03 |
| JP6663326B2 (ja) | 2020-03-11 |
| CN104023740B (zh) | 2018-10-02 |
| CA2840617A1 (en) | 2013-01-03 |
| CN109008910B (zh) | 2024-07-26 |
| JP6745866B2 (ja) | 2020-08-26 |
| EP2726091A4 (en) | 2015-04-15 |
| JP2016193946A (ja) | 2016-11-17 |
| ES2773115T3 (es) | 2020-07-09 |
| WO2013003824A1 (en) | 2013-01-03 |
| AU2012275112B2 (en) | 2017-07-06 |
| JP2019043967A (ja) | 2019-03-22 |
| PT2726091T (pt) | 2020-04-22 |
| JP7305008B2 (ja) | 2023-07-07 |
| JP2022126686A (ja) | 2022-08-30 |
| CN109008910A (zh) | 2018-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2726091T3 (pl) | Preparaty lecznicze dostarczane do kanału przewodu jelitowego za pomocą połykalnego urządzenia dostarczającego lek | |
| EP3316872A4 (en) | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | |
| IN2014CN00338A (pl) | ||
| EP2768571A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
| WO2011112229A3 (en) | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | |
| EP2593039A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
| EP2411083A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
| EP2453834A4 (en) | MEDICAL DEVICE DISPENSING MEDICINE | |
| PL3461478T3 (pl) | Połykalne urządzenie dostarczające lek | |
| GB2501214B (en) | Medicament delivery devices for administration of a medicament within a prefilled syringe | |
| EP2544741A4 (en) | APPARATUS FOR MEDICAMENT ADMINISTRATION | |
| EP2526986A4 (en) | DEVICE FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS | |
| LT2995240T (lt) | Aparatas, skirtas kontroliuoti kapsulinio endoskopo judėjimą žmogaus kūno virškinimo trakte | |
| PL2464342T3 (pl) | Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych | |
| EP2670458A4 (en) | APPARATUS FOR MEDICAMENT ADMINISTRATION | |
| EP2627382A4 (en) | APPARATUS FOR MEDICAMENT ADMINISTRATION | |
| ZA201400616B (en) | Methods and devices for drug delivery to ocular tissue using microneedle | |
| IL221166B (en) | A system for administering medication to a patient | |
| IL239488A0 (en) | A gpc3-targeted medicinal agent for the treatment of patients for whom treatment with a gpc3-targeted medicinal agent is beneficial | |
| EP2771043A4 (en) | ACTIVE RELEASE PROCEDURE | |
| EP2421587A4 (en) | APPARATUS FOR MEDICAMENT ADMINISTRATION | |
| EP2908874A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
| EP2775902A4 (en) | INFLATABLE CUFFS WITH INGREDIENT MEDICAMENT DELIVERY FOR DYNAMIC MEDICAMENT THERAPY AS A RESPONSE TO BLOOD PRESSURE PRECURSIONS | |
| PL2353632T3 (pl) | Urządzenie medyczne do miejscowego podawania leku | |
| EP2667857A4 (en) | ACTIVE RELEASE DEVICE |